時富投資(01049.HK)年度扭虧為盈至3998.5萬港元
格隆匯 3 月 12日丨時富投資(01049.HK)公吿,截至2020年12月31日止年度,實現收益13.8億港元,同比減少0.59%;股東應占淨利3998.5萬港元,去年則虧損9939.2萬港元,扭虧為盈;基本每股淨利65.47港仙,不派息。
面對猝不及防的地及全球經濟驟變、眾多不明朗因素及市場動盪,尤其在回顧年內新冠病毒疫情肆虐的環境下,公司仍能克渡時艱,並維持與去年相若的收益。另一方面,公司自2018年12月起實施的成優化計劃起了正面的作用,加上業主於新冠病毒疫情下作出租金寬免令租金成減少7%,及計入收取香港特區政府保就業計劃項下的資助令員工成亦減少16%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.